MENU
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Amylyx Pharmaceuticals (AMLX) Ownership - Who owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more
Profile
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
435.92M
P/E Ratio
2.69
Total Cash
176.5M
Projected Growth
N/A
Total Debt
1.98M
Revenue
87.37M
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash/Share
1.99
Total Debt/Equity
N/A
Revenue/Share
1.28 USD as % of share price
Fundamentals
AMLX
Capitalization
436M
P/E Ratio
2.69
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash
177M
Total Cash/Share
1.99
Total Debt
1.98M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.28%
Revenue
87.4M
ROE
N/A
Book Value
165M
P/B Ratio
2.65
Cash Flow
N/A
Earnings
-4.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
6.67
Current Revenue Per Employee
1083.33
Dividends Per Share - Security
N/A
EBITDA
-290.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
-94.47
Revenue To Assets
-84.87
Shares Held By Institutions
257M
Shares Outstanding - Current
88.6M
Total Liabilities
28.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
33.862
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com